KINETICS AND REQUIREMENTS FOR ACTIVATION OF MACROPHAGES FOR FUNGICIDAL ACTIVITY - EFFECT OF PROTEIN-SYNTHESIS INHIBITORS AND IMMUNOSUPPRESSANTS ON ACTIVATION AND FUNGICIDAL MECHANISM

被引:18
作者
BRUMMER, E
HANSON, LH
STEVENS, DA
机构
[1] STANFORD UNIV,MED CTR,SCH MED,STANFORD,CA 94305
[2] CALIF INST MED RES,SAN JOSE,CA 95128
关键词
D O I
10.1016/0008-8749(91)90022-4
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Peritoneal and pulmonary macrophages can be activated in vitro with lymphokines (LK) or IFN-γ, without exogenous lipopolysaccharide, for fungicidal activity against several pathogenic fungi. However, neither the biochemical nor metabolic events of the activation process or of the effector phase have been defined. In the present work we sought to elucidate these events with time-course studies using inhibitors of protein synthesis as well as immunosuppressive agents. We found that protein synthesis inhibitors abrogated the activation process, because cycloheximide (CHX) (1-2 μg/ml) prevented activation of macrophages for fungicidal activity against Candida albicans, Blastomyces dermatitidis, and Paracoccidioides brasiliensis. Blocking of the activation process by CHX was not due to macrophage cytotoxicity, and CHX did not impair the ability of nonactivated macrophages to kill Candida parapsilosis. In kinetic studies we showed that activation of macrophages was induced in 4 hr of LK treatment and that CHX had no effect if added after this time. In contrast to CHX, therapeutic concentrations of hydrocortisone (HC), such as ≤5 μg/ml, or cyclosporin A (CsA), 5 μg/ml, did not significantly inhibit LK activation of macrophages for killing of fungi. In the effector phase, the fungicidal capacity of activated macrophages in short-term (≤4 hr) killing assays could not be abrogated by CHX (5 μg/ml), HC (100 μg/ml), or CsA (10 μg/ml). These results demonstrate that the activation but not the effector mechanism of macrophages for fungicidal activity is blocked by inhibition of protein synthesis. In contrast, therapeutic concentrations of HC or CsA may not interfere with activation of macrophages or their killing mechanisms, thus providing a rationale for antifungal immunotherapy in certain clinical situations (e.g., infection in the immunosuppressed patient). © 1991.
引用
收藏
页码:236 / 245
页数:10
相关论文
共 32 条
[1]   FUNGICIDAL ACTIVATION OF MURINE MACROPHAGES BY RECOMBINANT GAMMA-INTERFERON [J].
BEAMAN, L .
INFECTION AND IMMUNITY, 1987, 55 (12) :2951-2955
[2]   ACTIVATION OF MACROPHAGES BY LYMPHOKINES - ENHANCEMENT OF PHAGOSOME-LYSOSOME FUSION AND KILLING OF COCCIDIOIDES-IMMITIS [J].
BEAMAN, L ;
BENJAMINI, E ;
PAPPAGIANIS, D .
INFECTION AND IMMUNITY, 1983, 39 (03) :1201-1207
[3]  
BRUMMER E, 1988, J IMMUNOL, V140, P2786
[4]   FUNGICIDAL MECHANISMS OF ACTIVATED MACROPHAGES - EVIDENCE FOR NONOXIDATIVE MECHANISMS FOR KILLING OF BLASTOMYCES-DERMATITIDIS [J].
BRUMMER, E ;
STEVENS, DA .
INFECTION AND IMMUNITY, 1987, 55 (12) :3221-3224
[5]   RECOMBINANT AND NATURAL GAMMA-INTERFERON ACTIVATION OF MACROPHAGES INVITRO - DIFFERENT DOSE REQUIREMENTS FOR INDUCTION OF KILLING ACTIVITY AGAINST PHAGOCYTIZABLE AND NONPHAGOCYTIZABLE FUNGI [J].
BRUMMER, E ;
MORRISON, CJ ;
STEVENS, DA .
INFECTION AND IMMUNITY, 1985, 49 (03) :724-730
[6]  
BRUMMER E, 1987, CLIN EXP IMMUNOL, V70, P520
[7]   ACTIVATION OF MURINE POLYMORPHONUCLEAR NEUTROPHILS FOR FUNGICIDAL ACTIVITY WITH SUPERNATANTS FROM ANTIGEN-STIMULATED IMMUNE SPLEEN-CELL CULTURES [J].
BRUMMER, E ;
STEVENS, DA .
INFECTION AND IMMUNITY, 1984, 45 (02) :447-452
[8]   GAMMA-INTERFERON ACTIVATION OF MACROPHAGES FOR KILLING OF PARACOCCIDIOIDES-BRASILIENSIS AND EVIDENCE FOR NONOXIDATIVE MECHANISMS [J].
BRUMMER, E ;
HANSON, LH ;
STEVENS, DA .
INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY, 1988, 10 (08) :945-952
[9]  
CASTANEDA E, 1988, J MED VET MYCOL, V26, P351
[10]  
HESS AD, 1981, J IMMUNOL, V126, P961